The slip
PARKINSON RECEIPTno. 10758
26 Oct 2026, 10:35 UTCdopamine neurons, braak
predictionSLC37A1 in dopamine neurons tracks Braak Lewy-body stage
registered8324699e1b6781b5
discovery-0.65 p=0.058 n=9
replication+0.03 p=0.929 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.65, p 0.058)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT917a0c43eb51e52bcc28c265…
follows 3c54b5a8bc0a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 10758: SLC37A1 in dopamine neurons, braak
- power
- full sample -0.35 (p 0.156, n 18), 95% CI -0.70 to +0.14. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.34 (p 0.167, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.49 (p 0.038, n 18). not the mix.
- skeptic
- leave-one-out range -0.51 to -0.27, sign flips 0; without severely affected donors -0.35 (p 0.156, n 18). fragile.
- cell type
- strongest in microglia: -0.65 (p 0.0034, n 18) vs -0.35 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC37A1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SLC37A1 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.20 p 0.477 (needs p < 2.1e-4)